Trial Profile
Long-term study on combinational therapy of SMP-508 with metformin in patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Repaglinide (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sumitomo Dainippon Pharma
- 20 May 2016 New trial record